Drugs / Human Recombinant Regular Insulin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02102243 | Nov 2010 → Dec 2025 | hypertensive disorder | Wanpen Vongpatanasin | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Recombinant Regular Insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02102243 ↗ |